Hyundai Hope On Wheels, a charity linked to the Hyundai Motor Company, has provided funding to enable more than one million COVID-19 tests at 23 testing sites nationwide.
In March, the company launched the funding initiative initially for 11 hospitals, which each received a $200,000 grant explicitly to be used for testing. Just after Easter, the company doubled the number receiving support. At the time, the $4 million in grant monies covered 22 hospitals in 16 states. An addition site was added later.
Additionally, Hyundai also provided an in-kind donation of 65,000 COVID-19 RT-PCR tests developed by Seegene, a South Korea-based global leader in multiplex molecular diagnostics. Hyundai’s headquarters is in South Korea. Seegene’s test can simultaneously detect three different genes (N, E and RdRP) of SARS-CoV-2, the virus responsible for COVID-19.
Hyundai and its over 825 dealers also provided support to local institutions with financial assistance, food donations, face mask headband production and loaned vehicles.
“We are grateful for the tireless work of the healthcare workers on the frontlines of the pandemic that made this milestone possible,” said Kevin Reilly, Board Member of Hyundai Hope On Wheels and President of Alexandria Hyundai. “Testing is the key to reopening our country safely and we are proud to support our partners in this ongoing and critical effort.”
In addition to COVID-19 tests, Hyundai Hope On Wheels provides grants to institutions that research pediatric cancers. Childhood Cancer Awareness Month in September, HHOW will award 26 new research grants totaling $6.2 million to researchers at children’s hospitals nationwide in their relentless pursuit of life-saving treatments. The company began their support of this aspect of the healthcare industry in 1998.